Hereditary haemorrhagic telangiectasia: From symptomatic management to pathogenesis based treatment.
Fernández-Fernández
Francisco José
FJ
D030301:Activin Receptors, Type II / Q000235:genetics; D015703:Antigens, CD / Q000235:genetics; D000071063:Endoglin; D006801:Humans; D009154:Mutation; D011956:Receptors, Cell Surface / Q000235:genetics; D015398:Signal Transduction; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D016212:Transforming Growth Factor beta / Q000378:metabolism
D015703:Antigens, CD; C064206:ENG protein, human; D000071063:Endoglin; D011956:Receptors, Cell Surface; D016212:Transforming Growth Factor beta; C425364:ACVRL1 protein, human; D030301:Activin Receptors, Type II